Impulse Control Disorder Among Parkinson's Disease Patients
Trial
N/A
Unknown
March 7, 2024
Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)
Trial
N/A
Completed
March 7, 2024
Safety and Efficacy of Liraglutide in Parkinson's Disease
Trial
Phase 2
Completed
March 6, 2024
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
Trial
N/A
Unknown
March 6, 2024
A Clinical Trial for the Safety and Effect of MRGuided FUS Subthalamotomy for Medication Refractory Parkinson's Disease
Trial
N/A
Completed
March 5, 2024
A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
Trial
Phase 2
Completed
March 5, 2024
Algorithm Guided DBS Programming in Parkinson's Patients
Trial
N/A
Unknown
March 5, 2024
Effect of Dopamine on Specific Processing of Shame and Embarrassment in Parkinson's Disease
Trial
N/A
Unknown
March 4, 2024
Effect of Intermittent Oro-esophageal Tube Feeding on Dysphagic Patients With Parkinson Disease
Trial
N/A
Withdrawn
March 4, 2024
Efficacy of Stellate Ganglion Block in Patients With Parkinson's Disease
Trial
N/A
Withdrawn
March 4, 2024
Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease
Trial
N/A
Unknown
March 4, 2024
Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease
Trial
N/A
Completed
March 3, 2024
Treating Bacterial Overgrowth in Parkinson's Disease
Trial
Phase 2
Completed
Feb. 29, 2024
A Study to Evaluate ENT-01 for the Treatment of Parkinson's Disease Dementia
Trial
Phase 1
Withdrawn
Feb. 29, 2024
Effect of Motor Function, Depression and Sleep Quality on Attention in Parkinson's Disease
Trial
N/A
Unknown
Feb. 27, 2024
Safety and Efficacy of State-of-the-Art Exoskeleton Technology to Improve Mobility in Parkinson's Disease
Trial
N/A
Terminated
Feb. 27, 2024
Ambroxol as a Treatment for Parkinson's Disease Dementia
Trial
Phase 2
Unknown
Feb. 27, 2024
A letter from Francis
News
Charco Neurotech
Feb. 26, 2024
High Fiber in Parkinson's Disease
Trial
Phase 1
Unknown
Feb. 25, 2024